184 related articles for article (PubMed ID: 31514489)
1. Soluble Receptor for Glycation End-products Concentration Increases Following the Treatment of Severe Diabetic Ketoacidosis.
Hoffman WH; Ishikawa T; Blum J; Tani N; Ikeda T; Artlett CM
J Clin Res Pediatr Endocrinol; 2020 Jun; 12(2):160-167. PubMed ID: 31514489
[TBL] [Abstract][Full Text] [Related]
2. Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study.
Melin EO; Dereke J; Hillman M
Lipids Health Dis; 2020 Oct; 19(1):223. PubMed ID: 33054750
[TBL] [Abstract][Full Text] [Related]
3. Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study.
Heier M; Margeirsdottir HD; Gaarder M; Stensæth KH; Brunborg C; Torjesen PA; Seljeflot I; Hanssen KF; Dahl-Jørgensen K
Cardiovasc Diabetol; 2015 Sep; 14():126. PubMed ID: 26408307
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults.
Palma-Duran SA; Kontogianni MD; Vlassopoulos A; Zhao S; Margariti A; Georgoulis M; Papatheodoridis G; Combet E
Metabolism; 2018 Jun; 83():120-127. PubMed ID: 29409822
[TBL] [Abstract][Full Text] [Related]
5. Dietary protein intake and circulating advanced glycation end product/receptor for advanced glycation end product concentrations in the Health, Aging, and Body Composition Study.
Brinkley TE; Semba RD; Kritchevsky SB; Houston DK;
Am J Clin Nutr; 2020 Dec; 112(6):1558-1565. PubMed ID: 33301008
[TBL] [Abstract][Full Text] [Related]
6. Association of four differently processed diets with plasma and urine advanced glycation end products and serum soluble receptor for advanced glycation end products concentration in healthy dogs.
Bridglalsingh S; Archer-Hartmann S; Azadi P; Barbier de La Serre C; Remillard RL; Sunvold GD; Bartges JW
J Anim Physiol Anim Nutr (Berl); 2024 May; 108(3):735-751. PubMed ID: 38279966
[TBL] [Abstract][Full Text] [Related]
7. [Correlation of the expressions of advanced glycation end products and its receptor in serum and placenta with the pathogenesis of preeclampsia].
Xian N; Chen W; Zhang Y; Li J; Zhang N; Ye Y
Zhonghua Fu Chan Ke Za Zhi; 2015 Jul; 50(7):493-9. PubMed ID: 26311638
[TBL] [Abstract][Full Text] [Related]
8. Transforming Growth Factor-β1 and Receptor for Advanced Glycation End Products Gene Expression and Protein Levels in Adolescents with Type 1 iabetes Mellitus.
Ninić A; Bojanin D; Sopić M; Mihajlović M; Munjas J; Milenković T; Stefanović A; Vekić J; Spasojević-Kalimanovska V
J Clin Res Pediatr Endocrinol; 2021 Feb; 13(1):61-71. PubMed ID: 32936764
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation end products are elevated in cystic fibrosis-related diabetes and correlate with worse lung function.
Hunt WR; Helfman BR; McCarty NA; Hansen JM
J Cyst Fibros; 2016 Sep; 15(5):681-8. PubMed ID: 26817932
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes.
Kopytek M; Ząbczyk M; Mazur P; Undas A; Natorska J
Cardiovasc Diabetol; 2020 Jun; 19(1):92. PubMed ID: 32552684
[TBL] [Abstract][Full Text] [Related]
11. The different roles for the advanced glycation end products axis in heart failure and acute coronary syndrome settings.
Paradela-Dobarro B; Agra RM; Álvarez L; Varela-Román A; García-Acuña JM; González-Juanatey JR; Álvarez E; García-Seara FJ
Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1050-1060. PubMed ID: 31371263
[TBL] [Abstract][Full Text] [Related]
12. Long-term physical activity leads to a significant increase in serum sRAGE levels: a sign of decreased AGE-mediated inflammation due to physical activity?
Sponder M; Campean IA; Emich M; Fritzer-Szekeres M; Litschauer B; Graf S; Dalos D; Strametz-Juranek J
Heart Vessels; 2018 Aug; 33(8):893-900. PubMed ID: 29368166
[TBL] [Abstract][Full Text] [Related]
13. Effect of insulin on the soluble receptor for advanced glycation end products (RAGE).
Lam JK; Wang Y; Shiu SW; Wong Y; Betteridge DJ; Tan KC
Diabet Med; 2013 Jun; 30(6):702-9. PubMed ID: 23432638
[TBL] [Abstract][Full Text] [Related]
14. A drop in the circulating concentrations of soluble receptor for advanced glycation end products is associated with seroconversion to autoantibody positivity but not with subsequent progression to clinical disease in children en route to type 1 diabetes.
Salonen KM; Ryhänen SJ; Forbes JM; Härkönen T; Ilonen J; Simell O; Veijola R; Groop PH; Knip M
Diabetes Metab Res Rev; 2017 May; 33(4):. PubMed ID: 27883367
[TBL] [Abstract][Full Text] [Related]
15. AGE-RAGE Interaction Does Not Explain the Clinical Improvements after Therapeutic Fasting in Osteoarthritis.
Drinda S; Franke S; Schmidt S; Stoy K; Lehmann T; Wolf G; Neumann T
Complement Med Res; 2018; 25(3):167-172. PubMed ID: 29433120
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of advanced glycation end products (AGEs) are increased and their soluble receptor (sRAGE) reduced in Hashimoto's thyroiditis.
Ruggeri RM; Barbalace MC; Cristani MT; Alibrandi A; Giovinazzo S; Giuffrida G; Trimarchi F; Cannavò S; Campennì A
J Endocrinol Invest; 2020 Sep; 43(9):1337-1342. PubMed ID: 32232775
[TBL] [Abstract][Full Text] [Related]
17. Circulating Ligands of the Receptor for Advanced Glycation End Products and the Soluble Form of the Receptor Modulate Cardiovascular Cell Apoptosis in Diabetes.
Tsoporis JN; Hatziagelaki E; Gupta S; Izhar S; Salpeas V; Tsiavou A; Rigopoulos AG; Triantafyllis AS; Marshall JC; Parker TG; Rizos IK
Molecules; 2020 Nov; 25(22):. PubMed ID: 33182705
[TBL] [Abstract][Full Text] [Related]
18. The Possible Impact of Hyperuricemia on Serum Soluble Receptor for Advanced Glycation end Products (sRAGE) Levels in Teenagers: A Case Control Study.
Lemiesz M; Tenderenda-Banasiuk E; Sosnowska D; Rybi-Szumińska A; Storonowicz J; Lemiesz T; Wasilewska A
Curr Pharm Des; 2018; 24(27):3232-3239. PubMed ID: 30101695
[TBL] [Abstract][Full Text] [Related]
19. Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE).
Nowak A; Przywara-Chowaniec B; Damasiewicz-Bodzek A; Blachut D; Nowalany-Kozielska E; Tyrpień-Golder K
Cells; 2021 Dec; 10(12):. PubMed ID: 34944030
[TBL] [Abstract][Full Text] [Related]
20. Dietary advanced glycated end-products and medicines influence the expression of SIRT1 and DDOST in peripheral mononuclear cells from long-term type 1 diabetes patients.
Santos-Bezerra DP; Machado-Lima A; Monteiro MB; Admoni SN; Perez RV; Machado CG; Shimizu MH; Cavaleiro AM; Thieme K; Queiroz MS; Machado UF; Giannella-Neto D; Passarelli M; Corrêa-Giannella ML
Diab Vasc Dis Res; 2018 Jan; 15(1):81-89. PubMed ID: 29027826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
